Javascript must be enabled to continue!
Simultaneous Heart and Kidney Transplantation utilizing Circulatory Death Donors in the United States
View through CrossRef
Abstract
Objective
Heart transplants utilizing donors from circulatory death (DCD) allografts are rapidly growing with the potential to expand the donor pool. However, little is known about the use of DCD donors for simultaneous heart and kidney transplants (SHKT) compared to SHKT using brain death donors (DBD).
Methods
From May 22, 2020, to September 30, 2023, 1,129 adult patients received SHKT (DCD, N=91 vs. DBD, N=1,038), identified using the United Network for Organ Sharing database, excluding other multi-organ transplants and re-transplants. A 1:3 ratio propensity score matching was performed using 17 recipient characteristics and 7 donor characteristics. A total of 91 DCD and 273 DBD matched cases were compared.
Results
In the unmatched cohort, DCD recipients were older (DCD: 60 vs. DBD: 58 years, p=0.03) and had a lower rate of dialysis at transplant (27% vs. 40%, p=0.03) and status 1 to 2 patients (43% vs. 72%, p<.001). Donors were younger (30 vs. 32 years, p=0.02) in the DCD group. In the matched cohort, kidney delayed graft function (27% vs. 22%, p=0.29) was comparable, as were recipient survival (p=0.19), heart graft survival (p=0.19), and kidney graft survival (p=0.17). In multivariate Cox proportional hazards analysis, donor type (DCD) was not associated with an increased risk of mortality (HR=1.69, 95% Cl 0.90-3.16, p=0.10). Sub-group analysis showed that survival and freedom from graft failures were comparable between different modes of DCD recovery. The centers performing both DCD- and DBD-SHKT showed significantly shorter waitlist days with comparable transplant outcomes compared to centers that only performed DBD-SHKT.
Conclusions
SHKT using DCD donors yields comparable survival and graft outcomes to those using DBD donors. These findings will guide treatment strategies for heart transplant candidates with kidney dysfunction, including the selection of donors and patients and safety net policy options.
Title: Simultaneous Heart and Kidney Transplantation utilizing Circulatory Death Donors in the United States
Description:
Abstract
Objective
Heart transplants utilizing donors from circulatory death (DCD) allografts are rapidly growing with the potential to expand the donor pool.
However, little is known about the use of DCD donors for simultaneous heart and kidney transplants (SHKT) compared to SHKT using brain death donors (DBD).
Methods
From May 22, 2020, to September 30, 2023, 1,129 adult patients received SHKT (DCD, N=91 vs.
DBD, N=1,038), identified using the United Network for Organ Sharing database, excluding other multi-organ transplants and re-transplants.
A 1:3 ratio propensity score matching was performed using 17 recipient characteristics and 7 donor characteristics.
A total of 91 DCD and 273 DBD matched cases were compared.
Results
In the unmatched cohort, DCD recipients were older (DCD: 60 vs.
DBD: 58 years, p=0.
03) and had a lower rate of dialysis at transplant (27% vs.
40%, p=0.
03) and status 1 to 2 patients (43% vs.
72%, p<.
001).
Donors were younger (30 vs.
32 years, p=0.
02) in the DCD group.
In the matched cohort, kidney delayed graft function (27% vs.
22%, p=0.
29) was comparable, as were recipient survival (p=0.
19), heart graft survival (p=0.
19), and kidney graft survival (p=0.
17).
In multivariate Cox proportional hazards analysis, donor type (DCD) was not associated with an increased risk of mortality (HR=1.
69, 95% Cl 0.
90-3.
16, p=0.
10).
Sub-group analysis showed that survival and freedom from graft failures were comparable between different modes of DCD recovery.
The centers performing both DCD- and DBD-SHKT showed significantly shorter waitlist days with comparable transplant outcomes compared to centers that only performed DBD-SHKT.
Conclusions
SHKT using DCD donors yields comparable survival and graft outcomes to those using DBD donors.
These findings will guide treatment strategies for heart transplant candidates with kidney dysfunction, including the selection of donors and patients and safety net policy options.
Related Results
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
Impact of Donation After Circulatory Death on Waitlist Duration and Early Outcomes in Heart Transplantation for Patients With Durable Mechanical Circulatory Support
Impact of Donation After Circulatory Death on Waitlist Duration and Early Outcomes in Heart Transplantation for Patients With Durable Mechanical Circulatory Support
Abstract
Objective
While heart transplantation primarily relies on donors after brain death, the use of donors after circ...
Follow-up of 12,559 Unrelated Donors of Peripheral Blood Stem Cells or Bone Marrow
Follow-up of 12,559 Unrelated Donors of Peripheral Blood Stem Cells or Bone Marrow
Abstract
Abstract 365
Donor follow-up is indicated to detect potential long-term risks for allogeneic stem cell donors. We sent a follow-up questionna...
Determinants of Willingness to Accept Kidney Transplantation Among Chronic Kidney Disease Patients in Ghana
Determinants of Willingness to Accept Kidney Transplantation Among Chronic Kidney Disease Patients in Ghana
Abstract
Background
The burden of chronic kidney disease in Africa is three to four times higher than high-income countries and the cost of treatment is beyond the reach o...
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Endemic regions for malaria are endemic for other infectious diseases that might affect the malaria infection. Infection with
hepatitis B virus (HBV) and hepatitis C virus (HCV) ar...
Kidney Tissue Reconstruction by Fetal Kidney Cell Transplantation: Effect of Gestation Stage of Fetal Kidney Cells
Kidney Tissue Reconstruction by Fetal Kidney Cell Transplantation: Effect of Gestation Stage of Fetal Kidney Cells
Abstract
Dialysis and kidney transplantation, current therapies for kidney failure, have limitations such as severe complications, donor shortage, and immune-related...
Dysmyelopoiesis In Healthy Bone Marrow Donors
Dysmyelopoiesis In Healthy Bone Marrow Donors
Abstract
Abstract 4006
Background:
According to WHO, the recommended requisite percentage of cells manifesting dy...
Non-Inferiority of Dual Kidney Transplantation: A Retrospective Matched Study
Non-Inferiority of Dual Kidney Transplantation: A Retrospective Matched Study
Background/Objectives: Dual kidney transplantation is a potential technique to reduce the number of discarded kidneys from expanded-criteria donors. Due to allegedly poor outcomes,...

